HPAP T2D: Human Pancreas Analysis Program (Univ. Pennsylvania)

Contact PI: Klaus Kaestner, PhD, University of Pennsylvania (U01DK123594)

Ali Naji, MD, PhD, Investigator, University of Pennsylvania
Ben Voight, PhD, Investigator, University of Pennsylvania
Doris Stoffers, MD, PhD, co-Investigator, University of Pennsylvania
Jason Moore, PhD, co-Investigator, University of Pennsylvania (09/2019-11/2021)
Michael Feldman, MD, PhD, co-Investigator, University of Pennsylvania (09/2019 – 03/2023)
Babak Faryabi, PhD, co-Investigator, University of Pennsylvania (11/2021-present)

Start Date: September 30, 2019


Abstract

The past decades have seen a dramatic improvement in our ability to phenotype and molecularly profile human tissues relevant to the etiology of type 2 diabetes with unprecedented resolution, at the genomic, epigenomic, protein, and functional levels.  Here we will employ state-of-the-art technologies to determine all aspects of pancreas biology as it pertains to type 2 diabetes, profile human pancreatic islets with multiple assay modalities, and make the vast data accumulated available through the highly accessible PANC-DB. This comprehensive profiling of the natural history of Type 2 diabetes will pave the way for future discoveries of new treatment modalities for diabetes.

 

HPAP logo

Meet the Grant Team

   Investigators 

 

Klaus Kaestner, PhD

University of Pennsylvania

 

Ali Naji, MD, PhD

University of Pennsylvania

 

Ben Voight, PhD

University of Pennsylvania

Doris Stoffers, MD, PhD

University of Pennsylvania

 

Jason Moore, PhD

University of Pennsylvania

 

 

Michael Feldman, MD, PhD

University of Pennsylvania

 

Publications

Follow
×

Follow

us on our social networks.